Highly favourable outcomes with peptide receptor radionuclide therapy (PRRT) for metastatic rectal neuroendocrine neoplasia (NEN) - Kong, G; Grozinsky-Glasberg, S; Hofman, MS (Eur J Nucl Med Mol Imaging, 2019)
et al.